Infections in patients on BCR-ABL tyrosine kinase inhibitor therapy: cases and review of the literature

Infection ◽  
2018 ◽  
Vol 46 (3) ◽  
pp. 409-418 ◽  
Author(s):  
Bettina M. Knoll ◽  
K. Seiter
Keyword(s):  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Kinase Inhibitor ◽  
Inhibitor Therapy ◽  
Review Of The Literature ◽  
Abl Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor Therapy ◽  
Abl Tyrosine Kinase Inhibitor

Cognitive dysfunction after withdrawal of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia

2016 ◽  
Vol 91 (11) ◽  
pp. E480-E481 ◽  
Author(s):  
Simone Claudiani ◽  
Jane F. Apperley ◽  
Simona Deplano ◽  
Jamshid Khorashad ◽  
Letizia Foroni ◽  
...  
Keyword(s):  
Chronic Myeloid Leukaemia ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Myeloid Leukaemia ◽  
Cognitive Dysfunction ◽  
Kinase Inhibitor ◽  
Inhibitor Therapy ◽  
Tyrosine Kinase Inhibitor Therapy

scholarly journals Skeletal muscle toxicity associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia

Leukemia ◽  
2019 ◽  
Vol 33 (8) ◽  
pp. 2116-2120 ◽  
Author(s):  
L. Janssen ◽  
S. J. C. M. Frambach ◽  
N. A. E. Allard ◽  
M. T. E. Hopman ◽  
T. J. J. Schirris ◽  
...  
Keyword(s):  
Skeletal Muscle ◽  
Chronic Myeloid Leukemia ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Myeloid Leukemia ◽  
Kinase Inhibitor ◽  
Inhibitor Therapy ◽  
Tyrosine Kinase Inhibitor Therapy ◽  
Muscle Toxicity
Sign in / Sign up

Export Citation Format

Share Document